308 related articles for article (PubMed ID: 36171554)
1. Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Wu J; Liu T; Shi S; Fan Z; Hiram R; Xiong F; Cui B; Su X; Chang R; Zhang W; Yan M; Tang Y; Huang H; Wu G; Huang C
Cardiovasc Diabetol; 2022 Sep; 21(1):197. PubMed ID: 36171554
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
Qin T; Kong B; Dai C; Xiao Z; Fang J; Shuai W; Huang H
Bioengineered; 2022 Feb; 13(2):2697-2709. PubMed ID: 35042435
[TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
[TBL] [Abstract][Full Text] [Related]
4. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
[TBL] [Abstract][Full Text] [Related]
7. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca
Fowler ED; Drinkhill MJ; Norman R; Pervolaraki E; Stones R; Steer E; Benoist D; Steele DS; Calaghan SC; White E
J Mol Cell Cardiol; 2018 Jul; 120():74-83. PubMed ID: 29807024
[TBL] [Abstract][Full Text] [Related]
8. Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease.
Dai C; Kong B; Shuai W; Xiao Z; Qin T; Fang J; Gong Y; Zhu J; Liu Q; Fu H; Meng H; Huang H
ESC Heart Fail; 2023 Feb; 10(1):578-593. PubMed ID: 36369767
[TBL] [Abstract][Full Text] [Related]
9. The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery Banding.
Connelly KA; Wu E; Visram A; Friedberg MK; Batchu SN; Yerra VG; Thai K; Nghiem L; Zhang Y; Kabir G; Desjardins JF; Advani A; Gilbert RE
Cardiovasc Drugs Ther; 2024 Feb; 38(1):57-68. PubMed ID: 36173474
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
Ye L; Jiang Y; Zuo X
Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
[TBL] [Abstract][Full Text] [Related]
12. Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.
Benoist D; Stones R; Drinkhill MJ; Benson AP; Yang Z; Cassan C; Gilbert SH; Saint DA; Cazorla O; Steele DS; Bernus O; White E
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2381-95. PubMed ID: 22427523
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension.
Tanaka S; Yamamoto T; Mikawa M; Nawata J; Fujii S; Nakamura Y; Kato T; Fukuda M; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Kobayashi S; Yano M
Heart Rhythm; 2022 Jun; 19(6):986-997. PubMed ID: 35134547
[TBL] [Abstract][Full Text] [Related]
14. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension.
Tanaka Y; Takase B; Yao T; Ishihara M
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):426-36. PubMed ID: 23600532
[TBL] [Abstract][Full Text] [Related]
16. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
17. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.
Chowdhury B; Luu AZ; Luu VZ; Kabir MG; Pan Y; Teoh H; Quan A; Sabongui S; Al-Omran M; Bhatt DL; Mazer CD; Connelly KA; Verma S; Hess DA
Biochem Biophys Res Commun; 2020 Mar; 524(1):50-56. PubMed ID: 31980166
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.
Redout EM; van der Toorn A; Zuidwijk MJ; van de Kolk CW; van Echteld CJ; Musters RJ; van Hardeveld C; Paulus WJ; Simonides WS
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1038-47. PubMed ID: 20061549
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.
Adão R; Mendes-Ferreira P; Maia-Rocha C; Santos-Ribeiro D; Rodrigues PG; Vidal-Meireles A; Monteiro-Pinto C; Pimentel LD; Falcão-Pires I; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):255-265. PubMed ID: 30339273
[TBL] [Abstract][Full Text] [Related]
20. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
